Search results for: 'biologics cdmo market'
- Related search terms
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
- biologics contract development ar manufacturing market forecast to 2024
- biologics contract development ar manufacturing market forecast to 2014
- biologics contract development ar manufacturing market forecast to 2025
-
06 Nov 2025  |  Global  |  Market Research
Global Genetic Testing Industry, Forecast of 2025–2030
Population Screening Initiatives, Reproductive Health Demand, and Clinical Risk Stratification are Accelerating Growth in Genetic Testing, Enabled by Advancements in Sequencing Technologies and Data-Driven Interpretation
This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...
$4,950.00 -
12 Sep 2016  |  North America  |  Market Research
Analysis of US Food Intolerance and Allergy Testing Market
Explore Potential Partners and Distribution Channels to Increase Market Position in the Direct-to-Consumer Pathway
The objective of this research is to understand the food intolerance and food allergy testing market in the United States. While allergy testing is common, food intolerance testing is provided by very few manufacturers, mostly as laboratory developed tests (LDTs) in the direct-to-consumer (DTC) pathway. The study includes key profiles of food intol...
$1,500.00
Special Price $1,125.00 save 25 %
-
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Growth Spurred by Simple and Accurate Point of Care (POC) Testing at Home for Urological Conditions such as Nephrolithiasis and Urinary Tract Infections (UTIs)
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
07 Aug 2026  |  Global  |  Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
An End-User Perspective on Spending and Growth Opportunities
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The survey provides companies with actionable trend insigh...
$4,950.00 -
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
17 Nov 2026  |  Global  |  Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and early detection of health conditions. This Frost Rada...
$4,950.00 -
18 Sep 2026  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offer strong compliance, secure centralized data manag...
$4,950.00 -
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00